Following encouraging trial findings , retatrutide, a novel peptide treatment for treating non-insulin dependent diabetes , has received regulatory approval from UK’s Drug and Healthcare Agency (MHRA https://elainejdaq833478.blog-mall.com/41754851/retatrutide-treatment-peptide-uk-approval-and-launch